Ionis Pharma (IONS) Q3 Revenue Tops Views
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $116.96 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
- AppFolio (APPF) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
